A small conference with big ambitions mirrors the rapid growth of Chinese biotech, invites comparisons to U.S. biotech ...

Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.

Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.

Hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing ...

The Department of Health and Human Services announced a set of new initiatives aimed at speeding up clinical trials by ...

In 2013, the House Republican, who had become the party’s de facto “chief political strategist,” was at a Virginia resort with his colleagues, working to shift the GOP away from its stereotype as a ...

This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine.

The CDC has updated its website to show two measles deaths in the U.S. this year. That means the agency is still out of step ...

The Trump administration published a final rule aimed at lowering Medicare prices for drugs administered in doctor offices. It applies to ...

Kratom has skirted regulation for decades, but newer, highly concentrated 7-OH products have renewed interest in safeguards.

The surest way to secure our biotech lead is to build up our own capabilities,” write Gary Locke and Patrick McHenry.

The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...